Brind.
  1. Nociscan is running the CLARITY clinical trial, which utilizes multiple sites including USC, Northwestern Medicine, and Johns Hopkins University.
  2. Aclarion is expanding Nociscan utilization in the U.K. and partnered with PRIA Healthcare for market access.

Aclarion's patent protects Nociscan workflow precision.

1 report, 1 independent Updated Aug 12
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Aclarion's patent protects Nociscan workflow precision.

Keep exploring

Part of

Aclarion is expanding Nociscan utilization in the U.K. and partnered with PRIA Healthcare for market access. All 1 developments

Within Nociscan is running the CLARITY clinical trial, which utilizes multiple sites including USC, Northwestern Medicine, and Johns Hopkins University.

Coverage

Newest first; wire copies grouped